Viking Therapeutics (VKTX) moved back into focus after its latest earnings release, as the biotech reported a third quarter net loss of US$183.19 million and wider losses over the first nine months of...
Source LinkViking Therapeutics (VKTX) moved back into focus after its latest earnings release, as the biotech reported a third quarter net loss of US$183.19 million and wider losses over the first nine months of...
Source Link
Comments